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Abstract
Iodine deficiency disorders (IDD) still represent a major public health problem, with 
almost 30% of the world population being exposed to the consequences of nutritional 
iodine deficiency (ID). In Italy, despite a sustained policy of iodine prophylaxis, more 
than 10% of people is still affected with goiter, and a presumably higher rate of subjects 
may suffer from minor cognitive deficits due to inadequate iodine supply during antena-
tal life. This review of systematic observational studies carried out over thirty-five years 
(1980-2015) in a sentinel ID area in North-eastern Sicily highlights the changing pheno-
types of IDD in this region. Over the years profound improvements in nutritional iodine 
status in North-eastern Sicily has occurred, due to both silent and active iodine prophy-
laxis. Endemic cretinism, resulting from severe iodine deficiency, has been progressively 
replaced by less serious deficits of intellectual and cognitive abilities, which nevertheless 
deserve proper attention. 
INTRODUCTION
Several lines of evidence have accumulated over 
the past 20 years, collectively demonstrating the im-
portance of thyroid hormone (TH) in regulating fetal 
neurodevelopment [1-8]. Prior to the onset of fetal 
thyroid function, the mother is the only source of thy-
roid hormone for the developing brain. By weeks 16-20 
post-conception, fetal thyroid gland development has 
occurred, and from this point onwards both the mother 
and fetus cooperate to make-up the fetal thyroid hor-
mone pool [6]. Any impairment of maternal and fetal 
thyroid function, occurring either independently or 
concomitantly, can result in brain damages and major 
or minor neuro-intellectual disorders in the offspring, 
the severity of which being dependent on the magni-
tude and length of TH deprivation, as well as on fetal 
age [9, 10]. 
Iodine deficiency (ID) still represents the most pre-
ventable cause of both maternal and fetal thyroid in-
sufficiency [11, 12]. The World Health Organization 
(WHO) recommends that pregnant women receive a 
daily iodine intake of 250 µg [13]. When this goal is 
not achieved, iodine intake is considered insufficient to 
prevent neuro-intellectual disorders. 
Over more than 30 years, ID disorders (IDD) af-
fecting people living in northeastern Sicily have been 
extensively studied, recorded and monitored. Iodine 
nutrition, which was severely deficient in the ’80s, pro-
gressively improved, as a result of the silent iodine pro-
phylaxis [14, 15], and more recently of a systematic and 
effective policy of iodine prophylaxis, mostly based on 
implementation of iodized salt consumption by house-
holds [16-18]. Nonetheless, non systematic epidemio-
logical data show iodine intake in this area to be less 
than adequate, and ID-related minor neurointellectual 
disorders still present. Focusing on how these disorders 
have been changing with the progressively improve-
ment of iodine nutrition status in local population is the 
objective of the present review.
EPIDEMIOLOGICAL AND CLINICAL 
CHARACTERISTICS OF THE STUDIED AREA
The first epidemiological characterization of IDD in 
different Sicilian areas was provided by Delange et al. in 
1978 [19]. At that time, those areas were approaching 
the severe iodine deficiency, since daily urinary iodine 
excretion (UIE) and goiter prevalence in schoolchildren 
were almost 25 µg/day and 50%, respectively. Moreover, 
endemic cretinism (myxedematous variant included) 
was known to be present in the same area. Since then, 
changes in the prevalence of IDD have occurred over 
almost 3 decades, mostly due to the improved distribu-
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tion network of frozen foods, including sea foods, and 
of industrially prepared dairy products, finally resulting 
in a progressive and “silent” increase in daily dietary io-
dine intake [14]. In addition, starting from 2005, iodine 
prophylaxis was implemented in Italy in the context of 
a nationwide program, by means of salt iodization [20]. 
Improvement in iodine nutrition status of local popu-
lation resulted in a significant increase in UIE (from 
62.2 ± 38.2 µg/L in 2000-2007 to 95.6 ± 25.8 µg/L in 
2012-2013), as well as in a decrease of goiter prevalence 
(from 16.3% in 2000-2007 to 7.6% in 2012-2013) in 
schoolchildren [21]. 
PHENOTYPES OF ID-RELATED 
NEUROINTELLECTUAL DISORDERS: 
FROM ENDEMIC CRETINISM TO “MINOR” 
NEUROLOGICAL DISORDERS
The spectrum of neurological disorders described in 
the endemic goiter areas in Sicily over the years encom-
passes severe clinical manifestations of ID, from en-
demic cretinism to subtle cognitive deficits, still present 
in some areas (Table 1).
Endemic cretinism
In 1981 [22] and 1990 [23], we described typical 
characteristics of endemic cretinism in an area charac-
terized by an even distribution of neurological, myxede-
matous and mixed clinical variants. The correlation of 
the three phenotypes to the birthdates of the affected 
subjects revealed that cretins born from 1970 onwards 
were affected exclusively with the neurological variant. 
This observation suggested the myxedematous forms, 
only observed in older subjects, to be the result of a 
more severe degree of iodine deficiency over a pro-
tracted period, and therefore affecting intrauterine life, 
(neurological damage), infancy, childhood, adolescence 
and adult life (myxedematous features) [23]. 
Endemic cognitive deficit (ECD)
Subsequent non systematic observational studies 
carried out in the same areas revealed that, far from 
being iodine sufficiency achieved, no more subjects af-
fected with endemic cretinism were born starting from 
the ’80s. However, a systematic study on prepubertal 
primary schoolchildren living in two iodine deficient ar-
eas within the same region and in age-matched school-
children from an iodine sufficient (IS) area, revealed 
the presence of defective or borderline performances 
in visual-perceptual and motor abilities in almost 14% 
and 17% ID schoolchildren, respectively, vs 3.5% in the 
control group [24]. The disorder, defined endemic cog-
nitive deficiency (ECD), was associated in one third of 
affected children to neurosensorial and neuromuscular 
abnormalities (disturbances in standing and gait, dysla-
lia, impaired hearing and deaf-mutism, increased ten-
don reflexes, clonus of the foot, Babinski sign), overall 
suggestive of a much less severe phenotype of endemic 
cretinism. Moreover, the vast majority of ECD chil-
dren and more than half borderline children scored at 
intelligence quotient (IQ) testing less than 90 points. 
Interestingly and at variance with endemic cretins, chil-
dren affected with ECD were clinically and biochemi-
cally euthyroid. This observation raised the question 
whether abnormality in thyroid function suffered by 
either expectant mothers or foetuses during gestation 
might account for ECD or other neurological disorders 
affecting the (euthyroid) progeny. This issue was ad-
dressed in two systematic studies evaluating changes of 
maternal thyroid function over gestation. Overall, these 
studies demonstrated a clear and progressive decline in 
Table 1
Overview of clinical and epidemiological studies carried out in ID areas in north-eastern Sicily from 1978 to 2016
Year Ref Main findings
1978 [19] Epidemiological characterization of IDD in different Sicilian areas, including the description of myxedematous variant of endemic cretinism. Median UIE: 25 µg/day; prevalence of goiter in schoolchildren > 50%
1989 [14] “Silent” iodine prophylaxis improves nutritional iodine status in general population: median UIE: 45 µg/day; prevalence of goiter in schoolchildren 26.5-44%a 
1990 [23]
Estimated prevalence of endemic cretinism in the general population in two ID areas in north-eastern Sicily: 0.13%. 
Description of 22 cretins living in the same ID areas showing either myxedematous, neurological or combined 
features of endemic cretinism
1990 [25] Description of a novel IDD (endemic cognitive deficit, ECD) characterized by defective IQ associated with neurosensorial and neromuscolar abnormalities, affecting 14% of apparently normal schoolchildren
1995 and 
1999 [26, 27]
Evidence of high prevalence of maternal thyroid failure during gestation (50% at midgestation and 70% at 
pregnancy term)
2004 [28]
ADHD diagnosed in almost 90% offspring of mothers exposed to mild-moderate ID during pregnancy and 
experiencing transient isolated hypothyroxinemia during the first half of gestation. Mean (± SD) UIE 62.2 ± 38.2 µg/L; 
prevalence of goiter in schoolchildren 16.3%
2008 [17] Prolonged use of iodized salt associated with a significantly reduced risk of maternal thyroid insufficiency during pregnancy (36.8% vs 6.4%; P 0.0005; relative risk 5.7, P 0.001)
2016 [21]
Threefold higher prevalence of decreased neurocognitive test outcomes  among children of unsupplemented 
mothers than among children born to mothers regularly consuming iodized salt (OR ~ 8 (95% CI, 2.4 to 24.9). Mean 
(± SD) UIE 95.6 ± 25.8 µg/L; prevalence of goiter in schoolchildren 7.6%
ID: iodine deficiency; IDD: iodine deficiency disorders; UIE: urinary iodine excretion; IQ; intelligence quotient; ADHD: attention deficit and hyperactivity disorder; a: 
different municipalities.
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maternal thyroid output with pregnancy progression, 
with 50% and 70% of women becoming hypothyroid at 
midgestation and at pregnancy term, respectively [25, 
26]. It is of note that the decline in maternal serum 
free-thyroxine (FT4) concentrations throughout gesta-
tion observed in these women was almost double that 
reported by Glinoer [27] in Bruxelles (37% vs 20%), a 
trend which was mirrored by a halved median UIE in 
our population compared to the Belgian women. In 
other words, a direct relationship between maternal 
iodine status and gestational thyroid function was ev-
ident, and the more severe the iodine deficiency, the 
higher the prevalence of maternal thyroid failure.
 
Attention deficit hyperactivity disorders (ADHD)
Based on the evidence of the previously described 
ECD and the high prevalence of maternal thyroid 
failure, further neurobehavioral and psychomotor 
systematic screenings were carried out in children 
born to ID mothers. Preliminary observations, made 
when children were 18-36 months old, had unexpect-
edly revealed symptoms suggestive of hyperactivity. 
The possibility that those features might be the initial 
symptoms of attention deficit hyperactivity disorders 
(ADHD) prompted us to re-evaluate these children 
when they had reached primary school age. The final 
study included 16 children born to healthy mothers liv-
ing in the above described ID area and 11 age-matched 
control children born to women from a marginally IS 
area [28]. In addition to neurological examination and 
ADHD screening, IQ by Wechsler Intelligence Scale 
for Children (WISC-III) [29, 30] was also measured. 
Neuromotor evaluation revealed no signs of neurologi-
cal impairment in any of the children. However, 68% 
of the children born to ID mothers was diagnosed with 
ADHD, whereas none of the IS area children was af-
fected with ADHD. In addition, total-IQ (t-IQ) score 
was lower in ADHD-positive (ADHD+ve) than in AD-
HD-negative (ADHD-ve) children by 11 points, and in 
both subgroups than in the control group by 22 and 
11 points, respectively. Finally, neurological results were 
found to be related to early-pregnancy maternal thyroid 
function, in that 87.5% of ID area mothers who expe-
rienced thyroid failure generated ADHD+ve children. 
Similarly, the children’s t-IQ score was directly (r = 0.56 
p < 0.005) related to maternal FT4 and inversely (r = 
0.63 p < 0.001) related to maternal TSH values at mid 
gestation. In conclusion, this study revealed, for the 
first time, the existence of a strong association between 
iodine deficiency and ADHD based on long-term ob-
servation of the neuropsychological and intelligence 
performances of children born to mothers from a mild-
moderate ID area.
Defective verbal abilities
Alongside these and other studies [31-39] showing 
a strong association between maternal thyroid insuffi-
ciency and neurobehavioral disorders in offspring, other 
evidence has been produced over the years not confirm-
ing a causal relationship between the above mentioned 
events [40-46]. In particular, the absence of intellectual 
impairment among children born to mothers severely 
hypothyroid in early pregnancy has been reported from 
Japan [45, 46], and the only randomized clinical trial 
investigating the effects of correcting (mild) maternal 
thyroid insufficiency by means of levothyroxine (LT4) 
therapy did not show improved cognitive outcomes in 
their offspring [47]. High differences in iodine nutrition 
status of pregnant women included in the above stud-
ies might account for these conflicting results. In fact, 
studies demonstrating a relationship between maternal 
thyroid function and impaired intellectual outcome of 
the offspring were mostly conducted in ID areas. Simi-
larly, the women in the study of Lazarus were from an 
area that, based on recent epidemiological surveys, 
may be classified as mildly ID [48]. Though thyroid 
insufficiency in these women was corrected by giving 
them LT4, their nutritional iodine intake was likely in-
adequate to guarantee fetal euthyroidism. Conversely, 
in the Japanese anecdotal case series [45, 46], despite 
the more severe maternal hypothyroidism, gestational 
nutritional iodine intake was more than adequate. All of 
this might suggest that gestational iodine status might 
play a more pivotal role than maternal thyroxinemia per 
se in determining neuro-intellectual outcomes in prog-
eny, likely by providing the fetus with adequate iodine 
amounts for his own thyroid hormone production. To 
examine whether iodine status of mothers or their thy-
roxinemia affects mental development of their children, 
we designed a pilot prospective observational study 
involving school-age children born to women who had 
been using iodized salt long before becoming pregnant 
(supplemented mothers) with that of children born to 
women never using it (unsupplemented mothers). A 
further stratification based on maternal LT4 treatment, 
uninterruptedly given prior to and during pregnancy, 
either in association or not with iodized salt consump-
tion, eventually allowed us to weigh up the effect of 
maternal nutritional iodine status against maternal thy-
roxinemia on cognitive outcome in the progeny. The 
primary outcomes were IQ tests (verbal, performance, 
and full-scale) performed in their children [21]. This 
study showed that, irrespective of LT4 treatment given 
to their mothers, children born to iodine-supplemented 
mothers had higher IQ scores than those born to un-
supplemented mothers (14, 10, and 13 points for verbal, 
performance, and t-IQ tests, respectively). Moreover, a 
threefold higher prevalence of decreased neurocogni-
tive test outcomes was found among children of un-
supplemented mothers than among children born to 
mothers who consumed iodized salt, this difference cor-
responding to an odds ratio of nearly 8 (95% CI, 2.4 to 
24.9) [21]. Thus, this study indicates that a significant 
improvement in IQ scores may be achieved by optimiz-
ing maternal iodine nutrition during preconception and 
pregnancy, and that it is largely independent of mater-
nal FT4 levels. This being the case, neurodevelopment 
may be more dependent on fetal than maternal thyroid 
function, and the less favourable cognitive outcomes 
observed in infants of unsupplemented mothers might 
be the result of the exposure of the developing brain to 
insufficient fetal TH levels, as a consequence of a low 
iodine availability. Interestingly, in our series of children 
verbal abilities were found to be more heavily affected, 
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with significant differences between verbal IQ (VIQ) 
and performance IQ found in children of unsupple-
mented mothers only. In addition, a significant associa-
tion between low maternal urinary iodine and defective 
VIQ was found. Overall, these findings are in keeping 
with others recently reported. The Avon Longitudinal 
Study of Parents and Children in the United Kingdom 
[49] showed that children born to mothers exposed to 
iodine deficiency during pregnancy were more likely 
to have lower VIQ and reading scores as compared 
with the children born to iodine sufficient mothers. 
Also, in a retrospective analysis of almost five-hundred 
mother-child pairs, Taylor et al. showed that maternal 
perchlorate levels in the highest 10% of the population 
increased the odds of offspring IQ < 80, with a greater 
negative impact observed on VIQ than PIQ [50]. The 
link between impaired verbal abilities and inadequate 
fetal iodine availability is presently unknown. However, 
a relatively low VIQ may be related to central auditory 
processing disorders (cAPDs) [51, 52]. These disor-
ders are not associated to peripheral hearing defects, 
and result from difficulties in the perceptual processing 
of auditory information in the central nervous system. 
Causes of cAPDs may include misplaced cells in the 
auditory cortical areas and/or delay in myelin matura-
tion [53, 54], both neurodevelopmental events known 
to be TH regulated [7]. Interestingly, cAPDs cover a 
wide range of behavioral disorders, including ADHD 
among others [55].
MATERNAL THYROID FUNCTION  
AND IODINE PROPHYLAXIS PROGRAMS
The evidence of minor neurointellectual disorders in 
schoolchildren living in the studied area prompted us to 
promote in 2003 a local program of iodine prophylaxis 
on a voluntary basis, encouraging iodized salt consump-
tion in women of child-bearing age and pregnant wom-
en living in the ID area where the aforementioned stud-
ies had been carried out. The program also included the 
monitoring of thyroid function over gestation and was 
aimed at early detection/correction of maternal thyroid 
underfunction, and ultimately prevent neurointellectual 
disorders in children. The efficacy of iodine prophy-
laxis using iodized salt in preventing maternal thyroid 
failure over gestation was prospectively evaluated in a 
study involving one hundred consecutive thyroperoxi-
dase antibody-negative pregnant women, two third of 
whom had regularly used iodized salt for at least 2 years 
prior to becoming pregnant and the remaining who 
commenced iodized salt consumption upon becoming 
pregnant [17]. This study showed that, compared to 
short-term iodine prophylaxis, prolonged use of iodized 
salt was associated with a significantly reduced risk of 
maternal thyroid insufficiency during pregnancy (36.8% 
vs 6.4%; P 0.0005; relative risk 5.7, P 0.001), likely be-
cause of the greater replenishment of intra-thyroidal 
iodine stores. However, even in the women who had 
been consuming iodized salt for a long period prior to 
pregnancy, median UIE at recruitment was indicative 
of inadequate iodine intake for pregnancy (115 mg/li-
ter, consistent with an estimated daily iodine intake of 
about 190 mg). In addition, a high prevalence of mater-
nal thyroid failure in women living in the same area was 
confirmed in a subsequent study [56]. For these rea-
sons, we launched a further information and awareness 
campaign urging general practitioners, gynaecologists 
and endocrinologists to advise locally resident preg-
nant women to use, in addition to iodized salt, iodine-
containing supplements. The efficacy of this method of 
iodine prophylaxis in guaranteeing adequate maternal 
thyroid hormone levels throughout gestation was then 
investigated [57]. The thyroid function of 168 women 
who had received prenatal preparations containing 150 
μg of iodine from early pregnancy was compared with 
that of either 105 women who had regularly used (> 
2 yrs) iodized salt prior to becoming pregnant or 160 
women who had neither taken iodine supplements nor 
used iodized salt. Overall, the regular use of iodine-con-
taining supplements proved effective to the same extent 
of long-term iodized salt consumption in reducing the 
risk of inappropriately low FT4 levels during pregnancy. 
Notably, women given iodine-containing supplements 
experienced a transient, although significant, increase 
in TSH levels, mostly occurring 4-6 weeks after iodine 
supplementation had been introduced. We speculated 
that this effect was a sort of transient stunning effect on 
the thyroid gland, due to the activation of autoregula-
tory mechanisms of iodine metabolism of even physio-
logical amounts of iodine (150 µg/day) within a chroni-
cally iodine-deprived thyroid gland. 
It is of note that the spectrum of maternal thyroid 
function disorders changed over the years, with isolated 
maternal hypothyroxinemia progressively becoming 
the more frequent manifestation of maternal thyroid 
insufficiency and, conversely, overt hypothyroidism oc-
curring only seldom [56]. Isolated hypothyroxinemia is 
characterized by low free-thyroxine levels, in the pres-
ence of TSH concentrations which fall within the nor-
mal range [10, 58]. This condition is assumed to be the 
result of an adaptive mechanism of maternal thyroid to 
inadequate iodine supply, and consists of a preferen-
tial triiodothyronine (T3) synthesis and secretion over 
thyroxine, ultimately aimed at sparing iodine. In such 
circumstances, circulating T3 is normal (or even slightly 
over the upper limit), and triggers negative feedback on 
pituitary TSH secretion, the concentrations of which 
fall within the normal range. As a result, the women 
are clinically euthyroid even when biochemically hy-
pothyroxinemic. If the condition of inadequate iodine 
supply persists, this compensatory mechanism may fail 
because of the inability of the maternal iodine pool to 
guarantee even T3 production, and overt hypothyroid-
ism thus occurs [10]. 
So far, maternal hypothyroxinemia, also observed in 
areas with adequate iodine intake, has been regarded as 
a normal condition, even though reduced intellectual 
performances have been reported in children born to 
iodine sufficient hypothyroxinemic mothers [34]. The 
growing concern that hypothyroxinemia during early 
gestation could be harmful to the fetus has also been 
reinforced by several clinical and experimental evi-
dences [5, 10, 28, 34-39, 59-68]. Nonetheless, there is 
not unanimous consensus on whether women found to 
be hypothyroxinemic should be given levo-thyroxine to 
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compensate their low FT4 levels [69-71], although it 
has been recently suggested that LT4 therapy may be 
considered if isolated hypothyroxinemia is detected in 
the first trimester of pregnancy [72]. However, it should 
be noted that FT4 immunoassays currently available are 
essentially FT4 estimate tests that do not measure se-
rum FT4 directly. While performing reasonably well in 
non-pregnant conditions, these methods are known to 
be sensitive to alterations in binding proteins and in-
terpretation of FT4 values in pregnant women requires 
method-specific ranges [73, 74].
Summarizing the above evidence, long-term (> 2 years) 
iodized salt consumption and iodine containing supple-
ments are both effective in minimizing, though not in 
completely eliminating, the risk of maternal thyroid fail-
ure. Indeed, estimations of iodine nutrition under those 
circumstances indicate the daily iodine intake from either 
iodized salt or iodine supplements alone to be below the 
requirements of pregnancy. In this view, we believe that in 
areas of mild-moderate iodine deficiency, which include 
several European countries [75], there is even greater 
justification for recommending long-term iodine supple-
mentation by means of both iodized salt and iodine-con-
taining supplements of women of child-bearing age prior 
to becoming pregnant. Such a strategy would reasonably 
guarantee the accumulation of sufficient iodine stores to 
meet the needs of both mother and foetus.
Finally, due to the high prevalence of gestational 
thyroid disorders [72, 76, 77] we believe that screen-
ing of thyroid function should be offered to all women 
planning a pregnancy and to women already pregnant, 
as soon as gestation is ascertained. In addition, the di-
agnostic and therapeutic challenges related to the sig-
nificant changes in thyroid economy during pregnancy 
[78], along with the severity of both obstetrical and 
post-natal complications of thyroid dysfunctions and 
related treatment [79-81], suggest the need to refer 
pregnant women diagnosed with thyroid diseases to 
specialized centers providing endocrinological and gyn-
aecological expertise. 
CONCLUSIONS
Over the last thirty years profound improvements 
in nutritional iodine status in north-eastern Sicily has 
occurred, due to both silent and active iodine prophy-
laxis. Based on recent data, mild iodine deficiency is 
still present in the region, and it is our hope that io-
dine sufficiency may be achieved in a next future by 
further implementation of iodine prophylaxis programs. 
The observed increase in iodine intake was mirrored by 
progressive changes in IDD phenotypes affecting local 
population. Endemic cretinism resulting from severe 
iodine deficiency has been progressively replaced by in-
tellectual and cognitive deficits that, although far less 
serious, cannot be disregarded.
At present, in Italy, despite a sustained iodized salt 
program, only 50% of the general population regularly 
consumes iodized salt [82]. This being the case, a high 
percentage of women of child-bearing age is likely to 
have iodine levels that are inadequate for the increased 
needs during pregnancy. 
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